254 related articles for article (PubMed ID: 36151395)
1. In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
Dubrot J; Du PP; Lane-Reticker SK; Kessler EA; Muscato AJ; Mehta A; Freeman SS; Allen PM; Olander KE; Ockerman KM; Wolfe CH; Wiesmann F; Knudsen NH; Tsao HW; Iracheta-Vellve A; Schneider EM; Rivera-Rosario AN; Kohnle IC; Pope HW; Ayer A; Mishra G; Zimmer MD; Kim SY; Mahapatra A; Ebrahimi-Nik H; Frederick DT; Boland GM; Haining WN; Root DE; Doench JG; Hacohen N; Yates KB; Manguso RT
Nat Immunol; 2022 Oct; 23(10):1495-1506. PubMed ID: 36151395
[TBL] [Abstract][Full Text] [Related]
2. The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes.
Lohwasser S; Kubota A; Salcedo M; Lian RH; Takei F
Int Immunol; 2001 Mar; 13(3):321-7. PubMed ID: 11222501
[TBL] [Abstract][Full Text] [Related]
3. Qa-1
Zhang X; Sabio E; Krishna C; Ma X; Wang J; Jiang H; Havel JJ; Chan TA
Mol Cancer Res; 2021 Jun; 19(6):1076-1084. PubMed ID: 33674442
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory receptor CD94/NKG2A on CD8
Eugène J; Jouand N; Ducoin K; Dansette D; Oger R; Deleine C; Leveque E; Meurette G; Podevin J; Matysiak T; Bennouna J; Bezieau S; Volteau C; Thomas WEA; Chetritt J; Kerdraon O; Fourquier P; Thibaudeau E; Dumont F; Mosnier JF; Toquet C; Jarry A; Gervois N; Bossard C
Mod Pathol; 2020 Mar; 33(3):468-482. PubMed ID: 31409873
[TBL] [Abstract][Full Text] [Related]
5. Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion.
Freeman AJ; Vervoort SJ; Ramsbottom KM; Kelly MJ; Michie J; Pijpers L; Johnstone RW; Kearney CJ; Oliaro J
Cell Rep; 2019 Sep; 28(11):2784-2794.e5. PubMed ID: 31509742
[TBL] [Abstract][Full Text] [Related]
6. NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.
van Montfoort N; Borst L; Korrer MJ; Sluijter M; Marijt KA; Santegoets SJ; van Ham VJ; Ehsan I; Charoentong P; André P; Wagtmann N; Welters MJP; Kim YJ; Piersma SJ; van der Burg SH; van Hall T
Cell; 2018 Dec; 175(7):1744-1755.e15. PubMed ID: 30503208
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeted interleukin-12 synergizes with entinostat to overcome PD-1/PD-L1 blockade-resistant tumors harboring MHC-I and APM deficiencies.
Minnar CM; Chariou PL; Horn LA; Hicks KC; Palena C; Schlom J; Gameiro SR
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764364
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma-mediated negative feedback regulation of NKT-cell function by CD94/NKG2.
Ota T; Takeda K; Akiba H; Hayakawa Y; Ogasawara K; Ikarashi Y; Miyake S; Wakasugi H; Yamamura T; Kronenberg M; Raulet DH; Kinoshita K; Yagita H; Smyth MJ; Okumura K
Blood; 2005 Jul; 106(1):184-92. PubMed ID: 15746081
[TBL] [Abstract][Full Text] [Related]
9. A herpesvirus encoded Qa-1 mimic inhibits natural killer cell cytotoxicity through CD94/NKG2A receptor engagement.
Wang X; Piersma SJ; Nelson CA; Dai YN; Christensen T; Lazear E; Yang L; Sluijter M; van Hall T; Hansen TH; Yokoyama WM; Fremont DH
Elife; 2018 Dec; 7():. PubMed ID: 30575523
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade.
Sato Y; Bolzenius JK; Eteleeb AM; Su X; Maher CA; Sehn JK; Arora VK
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518683
[TBL] [Abstract][Full Text] [Related]
11. A Single-Domain TCR-like Antibody Selective for the Qa-1
Ghaffari S; Upchurch-Ange K; Gimlin S; Tripathi T; Sluijter M; Middelburg J; van Hall T; Weidanz J
J Immunol; 2022 May; 208(9):2246-2255. PubMed ID: 35418467
[TBL] [Abstract][Full Text] [Related]
12. HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo.
Wischhusen J; Friese MA; Mittelbronn M; Meyermann R; Weller M
J Neuropathol Exp Neurol; 2005 Jun; 64(6):523-8. PubMed ID: 15977644
[TBL] [Abstract][Full Text] [Related]
13. Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway.
Lu L; Ikizawa K; Hu D; Werneck MB; Wucherpfennig KW; Cantor H
Immunity; 2007 May; 26(5):593-604. PubMed ID: 17509909
[TBL] [Abstract][Full Text] [Related]
14. Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells.
Chattopadhyay S; O'Rourke J; Cone RE
Int Immunol; 2008 Apr; 20(4):509-16. PubMed ID: 18359787
[TBL] [Abstract][Full Text] [Related]
15. Between Innate and Adaptive Immune Responses: NKG2A, NKG2C, and CD8⁺ T Cell Recognition of HLA-E Restricted Self-Peptides Acquired in the Absence of HLA-Ia.
Pump WC; Kraemer T; Huyton T; Hò GT; Blasczyk R; Bade-Doeding C
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909402
[TBL] [Abstract][Full Text] [Related]
16. Implications of NKG2A in immunity and immune-mediated diseases.
Wang X; Xiong H; Ning Z
Front Immunol; 2022; 13():960852. PubMed ID: 36032104
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
[TBL] [Abstract][Full Text] [Related]
18. Zika Virus Escapes NK Cell Detection by Upregulating Major Histocompatibility Complex Class I Molecules.
Glasner A; Oiknine-Djian E; Weisblum Y; Diab M; Panet A; Wolf DG; Mandelboim O
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878071
[TBL] [Abstract][Full Text] [Related]
19. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.
Braud VM; Allan DS; O'Callaghan CA; Söderström K; D'Andrea A; Ogg GS; Lazetic S; Young NT; Bell JI; Phillips JH; Lanier LL; McMichael AJ
Nature; 1998 Feb; 391(6669):795-9. PubMed ID: 9486650
[TBL] [Abstract][Full Text] [Related]
20. Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion.
Frangieh CJ; Melms JC; Thakore PI; Geiger-Schuller KR; Ho P; Luoma AM; Cleary B; Jerby-Arnon L; Malu S; Cuoco MS; Zhao M; Ager CR; Rogava M; Hovey L; Rotem A; Bernatchez C; Wucherpfennig KW; Johnson BE; Rozenblatt-Rosen O; Schadendorf D; Regev A; Izar B
Nat Genet; 2021 Mar; 53(3):332-341. PubMed ID: 33649592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]